FAM
VRTX icon

Formidable Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Formidable Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Buy
3,518
+1,548
+79% +$686K 0.26% 79
2026
Q1 		$885K Buy
1,970
+59
+3% +$27.5K 0.14% 147
2025
Q4 		$823K Sell
1,911
-76
-4% -$32.8K 0.12% 166
2025
Q3 		$820K Sell
1,987
-32
-2% -$13.4K 0.13% 161
2025
Q2 		$931K Sell
2,019
-82
-4% -$37.8K 0.16% 126
2025
Q1 		$1.02M Buy
2,101
+14
+0.7% +$6.52K 0.17% 115
2024
Q4 		$840K Sell
2,087
-123
-6% -$57K 0.14% 142
2024
Q3 		$1.03M Sell
2,210
-61
-3% -$29.3K 0.16% 120
2024
Q2 		$1.06M Sell
2,271
-248
-10% -$108K 0.17% 125
2024
Q1 		$1.05M Buy
2,519
+555
+28% +$235K 0.17% 115
2023
Q4 		$799K Sell
1,964
-657
-25% -$243K 0.17% 118
2023
Q3 		$912K Buy
2,621
+179
+7% +$62.6K 0.2% 95
2023
Q2 		$859K Sell
2,442
-124
-5% -$41.8K 0.19% 98
2023
Q1 		$808K Sell
2,566
-2,127
-45% -$638K 0.17% 106
2022
Q4 		$1.35M Hold
4,693
– – 0.31% 60
2022
Q3 		$1.36M Buy
4,693
+107
+2% +$30.8K 0.32% 60
2022
Q2 		$1.29M Buy
+4,586
New +$1.23M 0.29% 67
2019
Q2 		– Sell
-19,575
Closed -$938K – 339
2019
Q1 		$938K Buy
+19,575
New +$3.62M 0.37% 68

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Formidable Asset Management's VRTX Position: Q2 2026 in Review

Formidable Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 79% in Q2 2026, buying an estimated $686K and bringing the position to 3,518 shares worth $1.63M. The position accounts for 0.26% of the portfolio, ranked #79.

Formidable Asset Management first reported a position in VRTX in Q1 2019 and has held it in 18 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Formidable Asset Management held 3,518 shares of Vertex Pharmaceuticals worth $1.63M as of Q2 2026.
  • Formidable Asset Management bought 1,548 Vertex Pharmaceuticals shares in Q2 2026, an estimated $686K.
  • Vertex Pharmaceuticals made up 0.26% of Formidable Asset Management's portfolio in Q2 2026, its #79 holding.
  • Formidable Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 18 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.